HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitochondrial DNA Polymerase POLG1 Disease Mutations and Germline Variants Promote Tumorigenic Properties.

Abstract
Germline mutations in mitochondrial DNA polymerase gamma (POLG1) induce mitochondrial DNA (mtDNA) mutations, depletion, and decrease oxidative phosphorylation. Earlier, we identified somatic mutations in POLG1 and the contribution of these mutations in human cancer. However, a role for germline variations in POLG1 in human cancers is unknown. In this study, we examined a role for disease associated germline variants of POLG1, POLG1 gene expression, copy number variation and regulation in human cancers. We analyzed the mutations, expression and copy number variation in POLG1 in several cancer databases and validated the analyses in primary breast tumors and breast cancer cell lines. We discovered 5-aza-2'-deoxycytidine led epigenetic regulation of POLG1, mtDNA-encoded genes and increased mitochondrial respiration. We conducted comprehensive race based bioinformatics analyses of POLG1 gene in more than 33,000 European-Americans and 5,000 African-Americans. We identified a mitochondrial disease causing missense variation in polymerase domain of POLG1 protein at amino acid 1143 (E1143G) to be 25 times more prevalent in European-Americans (allele frequency 0.03777) when compared to African-American (allele frequency 0.00151) population. We identified T251I and P587L missense variations in exonuclease and linker region of POLG1 also to be more prevalent in European-Americans. Expression of these variants increased glucose consumption, decreased ATP production and increased matrigel invasion. Interestingly, conditional expression of these variants revealed that matrigel invasion properties conferred by these germline variants were reversible suggesting a role of epigenetic regulators. Indeed, we identified a set of miRNA whose expression was reversible after variant expression was turned off. Together, our studies demonstrate altered genetic and epigenetic regulation of POLG1 in human cancers and suggest a role for POLG1 germline variants in promoting tumorigenic properties.
AuthorsBhupendra Singh, Kjerstin M Owens, Prachi Bajpai, Mohamed Mokhtar Desouki, Vinodh Srinivasasainagendra, Hemant K Tiwari, Keshav K Singh
JournalPloS one (PLoS One) Vol. 10 Issue 10 Pg. e0139846 ( 2015) ISSN: 1932-6203 [Electronic] United States
PMID26468652 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • DNA Polymerase gamma
  • DNA-Directed DNA Polymerase
  • POLG protein, human
Topics
  • Breast Neoplasms (genetics, metabolism)
  • Cell Line, Tumor
  • Cell Transformation, Neoplastic (genetics)
  • DNA Copy Number Variations
  • DNA Polymerase gamma
  • DNA-Directed DNA Polymerase (genetics, metabolism)
  • Epigenesis, Genetic
  • Female
  • Gene Expression
  • Gene Expression Regulation, Neoplastic
  • Gene Frequency
  • Germ-Line Mutation
  • Humans
  • Mitochondria (genetics, metabolism)
  • Mitochondrial Diseases (complications, genetics)
  • Mutation
  • Neoplasms (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: